Found: 12
Select item for more details and to access through your institution.
Primary plasma cell leukaemia presenting with flower‐shaped nuclei.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 4, p. 689, doi. 10.1111/bjh.17320
- By:
- Publication type:
- Article
Safety of switching from intravenous to subcutaneous rituximab during first‐line treatment of patients with non‐Hodgkin lymphoma: the Spanish population of the MabRella study.
- Published in:
- British Journal of Haematology, 2020, v. 188, n. 5, p. 661, doi. 10.1111/bjh.16227
- By:
- Publication type:
- Article
Treatment burden in multiple myeloma according to comorbidity in real life.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Treatment patterns and outcomes in real-world transplant-ineligible patients newly diagnosed with multiple myeloma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Velcadito: Low dose of bortezomib with melphalan and prednisone for ≥75‐year‐olds newly diagnosed with multiple myeloma.
- Published in:
- European Journal of Haematology, 2022, v. 108, n. 6, p. 532, doi. 10.1111/ejh.13760
- By:
- Publication type:
- Article
Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM).
- Published in:
- PLoS ONE, 2021, v. 16, n. 9, p. 1, doi. 10.1371/journal.pone.0257353
- By:
- Publication type:
- Article
Real-World Health Care Services Utilization Associated With the Management of Patients With Relapsed and Refractory Multiple Myeloma in Spain: The CharisMMa Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 10, p. e341, doi. 10.1016/j.clml.2023.07.006
- By:
- Publication type:
- Article
Pomalidomide, Cyclophosphamide, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma: Real-World Analysis of the Pethema-GEM Experience.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Prescription Patterns and Outcomes of First-Line Therapy for Non-Transplant Eligible Multiple Myeloma Real-Life Patients According to Age: A Retrospective Analysis of the 2012-2016 Period.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e237, doi. 10.1016/j.clml.2019.09.395
- By:
- Publication type:
- Article
Risk of progression in smouldering myeloma and monoclonal gammopathies of unknown significance: comparative analysis of the evolution of monoclonal component and multiparameter flow cytometry of bone marrow plasma cells.
- Published in:
- British Journal of Haematology, 2010, v. 148, n. 1, p. 110, doi. 10.1111/j.1365-2141.2009.07929.x
- By:
- Publication type:
- Article
Lenalidomide treatment for patients with multiple myeloma: diagnosis and management of most frequent adverse events.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Ultrafast 30‐min infusion of a rituximab biosimilar (Truxima).
- Published in:
- EJHaem, 2023, v. 4, n. 4, p. 1196, doi. 10.1002/jha2.812
- By:
- Publication type:
- Article